Quantcast
Last updated on April 19, 2014 at 13:20 EDT

Latest Urinary bladder Stories

2010-11-16 14:27:00

EAST NORRITON, Pa., Nov. 16, 2010 /PRNewswire-FirstCall/ -- Tengion, Inc. (Nasdaq: TNGN), a leader in regenerative medicine, announced today that the scheduled one-month, post-operative clinical assessment of the first implanted bladder cancer patient in its ongoing clinical trial has been completed as expected and has permitted the second patient to be enrolled without delay. The protocol for this initial clinical trial calls for each of the first few patient implantations to occur at...

2010-11-16 13:47:00

MINNEAPOLIS, Nov. 16, 2010 /PRNewswire/ -- TIME OUT! PUT THE SPOTLIGHT ON ONE OF THE MOST COMMON AND LEAST DISCUSSED WOMEN'S HEALTH ISSUES - bladder control problems. This November, as part of the Facing Our Moments Together campaign, women around the country will take a Girls' Time Out to face the moments when they have struggled with bladder control problems. Did you know that more than 33 million people in the United States - or one in six adults - deal with bladder control problems?...

2010-10-27 10:19:00

MINNEAPOLIS, Oct. 27 /PRNewswire/ -- Uroplasty, Inc. (Nasdaq: UPI), announced today that the United Kingdom's National Institute for Health and Clinical Excellence (NICE) issued a guidance document titled "Percutaneous Posterior Tibial Nerve Stimulation for Overactive Bladder Syndrome," reinforcing the safety and effectiveness of PTNS for overactive bladder. "The significance of this guidance in the U.K. is a positive statement affirming the evidence that PTNS is efficacious in reducing...

2010-10-26 07:30:00

EAST NORRITON, Pa., Oct. 26 /PRNewswire-FirstCall/ -- Tengion, Inc. (Nasdaq: TNGN), a leader in regenerative medicine, today announced it will host a conference call and live audio webcast on Monday, November 1, 2010 at 5:00 p.m. EDT to provide a business update and discuss its third quarter 2010 financial results. To participate in the call, please dial 888.713.4213 (domestic) or 617.213.4865 (international) and reference the access code 30673244. This conference call will also be...

2010-10-25 07:30:00

EAST NORRITON, Pa., Oct. 25 /PRNewswire-FirstCall/ -- Tengion, Inc. (Nasdaq: TNGN), a leader in regenerative medicine, announced today that surgeons at the University of Chicago have implanted its Neo-Urinary Conduit(TM) in the first patient as part of the ongoing clinical trial evaluating the Company's lead product candidate in bladder cancer patients requiring a urinary diversion following bladder removal. The patient is being treated at the University of Chicago Medical Center by the...

2010-10-20 05:30:00

MINNEAPOLIS, Oct. 20 /PRNewswire-FirstCall/ -- Uroplasty, Inc. (Nasdaq: UPI) announced today that it will release financial results for the second quarter ended September 30, 2010, at the market close on Wednesday, October 27, 2010. The Company will host a conference call to discuss these results on Wednesday, October 27, 2010 at 3:30 p.m. Central Time. David Kaysen, President and Chief Executive Officer, and Medi Jiwani, Vice President, Chief Financial Officer and Treasurer, will host...

2010-10-19 08:07:00

Fifth Most Frequently Diagnosed Cancer in U.S. Affects Approximately 70,000 Americans Each Year NEW YORK, Oct. 19 /PRNewswire-USNewswire/ -- Bladder cancer is the fifth most commonly diagnosed cancer in the United States, yet most people know nothing about it. To help enhance the public's understanding of the risks and signs of bladder cancer and the importance of early detection and treatment options, the Bladder Cancer Advocacy Network (BCAN) will hold its regional Bladder Cancer...

2010-09-29 12:34:39

Scientists may have discovered a way to diagnose bladder cancer at its earliest and, therefore, most treatable stages by measuring the presence or absence of microRNA using already available laboratory tests. "Measuring expressions of microRNA in bodily fluid represents a very promising tool with widespread implications for screening," said Liana Adam, M.D., Ph.D., assistant professor in urology at The University of Texas MD Anderson Cancer Center. Adam presented her findings at the Fourth...

2010-09-27 14:56:00

BELLEVILLE, ON, Sept. 27 /PRNewswire-FirstCall/ - Bioniche Life Sciences Inc. (TSX: BNC), a research-based, technology driven Canadian biopharmaceutical company, has noted substantial share trading volume and share price increase over recent days. Management believes that this market activity is driven by expectation of a disclosure concerning its U.S. Food and Drug Administration (FDA) Phase III Fast Track clinical trial with Urocidin(TM) a product for non-muscle-invasive bladder cancer that...

2010-09-23 08:27:00

MINNEAPOLIS, Sept. 23 /PRNewswire/ -- Uroplasty, Inc. (Nasdaq: UPI), a medical device company that develops, manufactures and markets innovative proprietary products to treat voiding dysfunctions, today highlighted results of a study "Percutaneous Tibial Nerve Stimulation Effects on Detrusor Overactivity Incontinence Are Not Due to a Placebo Effect: A Randomized, Double-Blind, Placebo Controlled Trial," to be published in the November 2010 print edition of THE JOURNAL OF...


Latest Urinary bladder Reference Libraries

Urinary Bladder
2013-01-18 10:29:10

The urinary bladder is a hollow organ that holds the urine, a fluid by-product excreted from the kidneys. Once enough urine is collected within the bladder, pressure initiates the process of urination which expels the urine from the system completely. Formation and Orientation Bladders are a common organ in the Animal Kingdom but are unique in characteristics to each species. Within the human species, there are some differences between female and male bladders. The first difference is...

More Articles (1 articles) »